Get access to our best features
Get access to our best features
Published 28 days ago

Vaccine Manufacturer Moderna Announces Super News: Optimism Is Huge

Summary by Portfolio.hu
Moderna shares posted an 8% rise after their personalized cancer vaccine, developed in partnership with Merck, showed positive results in an early-stage trial targeting a type of head and neck cancer, giving promising signs to prepare the immune system against cancer cells.

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)